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Abstract
Background: Autonomic dysfunction appears to play a significant role in the development of atrial
fibrillation (AF), and impaired heart rate recovery (HRR) during exercise treadmill testing (ETT) is
a known marker for autonomic dysfunction. However, whether impaired HRR is associated with
incident AF is unknown. We studied the association of impaired HRR with the development of
incident AF, after controlling for demographic and clinical confounders.
Methods: We studied 8236 patients referred for ETT between 2001 and 2004, and without a prior
history of AF. Patients were categorized by normal or impaired HRR on ETT. The primary outcome
was the development of AF. Cox proportional hazards modeling was used to control for
demographic and clinical characteristics. Secondary analyses exploring a continuous relationship
between impaired HRR and AF, and exploring interactions between cardiac medication use, HRR,
and AF were also conducted.
Results: After adjustment, patients with impaired HRR were more likely to develop AF than
patients with normal HRR (HR 1.43, 95% confidence interval (CI) 1.06, 1.93). In addition, there was
a linear trend between impaired HRR and AF (HR 1.05 for each decreasing BPM in HRR, 95% CI
0.99, 1.11). No interactions between cardiac medications, HRR, and AF were noted.
Conclusion: Patients with impaired HRR on ETT were more likely to develop new-onset AF, as
compared to patients with normal HRR. These findings support the hypothesis that autonomic
dysfunction mediates the development of AF, and suggest that interventions known to improve
HRR, such as exercise training, may delay or prevent AF.
Background
Atrial fibrillation (AF) is a common condition in the U.S.,
with over 75,000 new cases annually.[1] Though its etiol-
ogy is multi-factorial, prior mechanistic studies have dem-
onstrated that autonomic dysfunction in general, and
decreased parasympathetic function in particular, may
play a significant role in its development. [2-5] Thus, clin-
ical tests that measure autonomic dysfunction may iden-
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tify patients at a higher likelihood of developing AF,
providing further support to the hypothesis that auto-
nomic dysfunction is a mediator of the condition.
Exercise treadmill testing (ETT) is a widely available clini-
cal tool that provides an assessment of autonomic dys-
function via measurement of heart rate recovery (HRR).
Impaired HRR, defined as a decrease of less than 12 beats
one minute after peak exercise, is associated with
decreased parasympathetic activity, and thus may identify
patients more likely to develop AF.
Accordingly, we hypothesized that patients with impaired
HRR on ETT were more likely to develop new-onset AF as
compared to those patients with normal HRR, after
adjustment for demographic and clinical factors associ-
ated with AF. Demonstration of an association between
AF and impaired HRR during ETT would add to the basic
physiologic, animal, and clinical observation studies sup-
porting the concept of the autonomic nervous system as a
potential mediator of AF.[2]
Methods
Study population and data collection
We examined a consecutive, prospective cohort of
patients without a prior diagnosis of AF or atrial flutter
who were referred for ETT between July 2001 and June
2004. All patients were enrolled in Kaiser Permanente of
Colorado (KPCO), an integrated, nonprofit managed care
organization (MCO) that provides medical services to
more than 475,000 members in the Denver/Boulder/
Colorado Springs, Colorado metropolitan area. Inclusion
criteria for the study included a minimum of 12 months
of KPCO enrollment prior to the index ETT, no prior diag-
nosis of AF or atrial flutter in either claims or medical
record data prior to or during the index ETT, and no use of
class I or III anti-arrhythmic drugs at the time of the index
ETT.
Prior to exercise testing, a structured history and medical
record review were performed to document symptoms,
past medical history, medication use, cardiac risk factors,
and prior cardiac events and procedures. Additional co-
morbidity data (e.g., cerebrovascular and peripheral vas-
cular disease) were obtained from the KPCO databases.
Symptom-limited exercise treadmill testing was per-
formed according to standardized protocols, with the
Bruce protocol used in 85% of tests. After achievement of
peak exercise, all patients underwent a 1 minute 'cool-
down' period by walking on the treadmill at 1.0 mile per
hour, as specified in prior research on HRR.[6] During
each exercise stage and recovery stage, symptoms (e.g.,
chest pain, shortness of breath, fatigue, dyspnea, and diz-
ziness), blood pressure, heart rate, cardiac rhythm, and
metabolic equivalents (METs) were recorded. The reasons
for termination of exercise, including dyspnea, fatigue,
chest pain, ischemic ST changes, marked elevation in
blood pressure, or ventricular ectopy were recorded.
Achieving target heart rate alone was not used as a justifi-
cation for terminating exercise. All clinical and exercise
data were entered contemporaneously into an electronic
database. For patients undergoing multiple treadmill tests
during this period, only the first treadmill test was consid-
ered in the analyses.
Variables
Our independent predictor variable of interest was abnor-
mal HRR, defined as a decrease of 12 beats/min or less
from peak exercise heart rate and one minute into recov-
ery.[6] Our primary outcome of interest was the occur-
rence of new-onset AF during the follow-up period, as
determined by the presence of a 427.31 ICD-9 code in a
facility claim or clinic visit. Follow-up information was
available after the exercise test on 99% of patients through
October 31, 2005. Patients who died or disenrolled from
Kaiser during the observation period were censored at the
time of disenrollment in the analyses.
Statistical Analysis
After categorization of patients by normal or abnormal
HRR, baseline characteristics were compared using the
chi-square test for categorical variables and Wilcoxon
rank-sum scores for continuous variables. Next, unad-
justed comparisons of time to new-onset AF by normal or
impaired HRR were performed using the log-rank test and
graphically represented by Kaplan-Meier curves. Then,
multivariable Cox proportional hazard models were con-
structed to determine the association between impaired
HRR and new-onset AF, adjusting for covariates. Co-vari-
ates entered into the multivariable model were selected
based on a priori research or those identified in bi-variate
analyses as associated with AF. Selected co-variates
included age, gender, hypertension, congestive heart fail-
ure, coronary artery disease, mitral valve disease, obesity,
and diabetes. [7-12] Age and gender, then clinical varia-
bles, were entered into the model sequentially to assess
for incremental effects on the primary association and
potential co-linearity. Cox proportional hazards assump-
tions were tested using Schoenfeld residuals.
In order to determine if the severity of impaired HRR was
associated with new-onset AF in a dose-response relation-
ship, we conducted a secondary analysis examining
abnormal HRR values (HRR ≤ 12) as a continuous varia-
ble and its linear association with new-onset AF In addi-
tion, since medication use (ACEI, beta-blocker, and statin
medications) may affect the development of new-onset
AF, [13-16] we also conducted a secondary analysis of the
association between HRR and new-onset AF incorporating
their use.BMC Cardiovascular Disorders 2009, 9:11 http://www.biomedcentral.com/1471-2261/9/11
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The study was approved by the Kaiser Permanente Colo-
rado Institutional Review Board. All analyses were per-
formed using the SAS statistical package version 9.1 (SAS
Institute, Cary, NC).
Results
Descriptives
Of 9569 patients undergoing ETT during the study period,
1128 patients did not meet the inclusion criteria or had
missing HRR data, resulting in 8236 patients for the study
cohort (Figure 1). Patient demographics, clinical history,
and ETT indications and characteristics are listed in Table
1. In general, patients with impaired HRR were older,
female, and had a higher prevalence of cardiac risk factors,
pre-existing CAD, and other co-morbidities as compared
to patients with normal HRR. The median length of fol-
low-up was 3.1 years.
Unadjusted and adjusted associations
During the study period, 99 (4.1%) patients with
impaired HRR and 93 (1.6%) patients with normal HRR
had new-onset AF (Figure 2, log-rank p-value < 0.0001).
After adjustment for age and gender, impaired HRR was
significantly associated with a higher risk of new-onset AF
(hazard ratio (HR) 1.55, 95% confidence interval (CI)
1.15, 2.08), as compared to patients with normal HRR
(Table 2). After adjustment for age, gender, and clinical
factors, impaired HRR remained significantly associated
with a higher risk of new-onset AF (HR 1.43, 95% CI 1.06,
1.93), as compared to patients with normal HRR (Table
2).
Secondary analyses
In secondary analyses, there was a trend towards a linear
relationship between impaired HRR and new-onset AF
(HR 1.05 for each decreasing BPM in HRR, 95% CI 0.99,
1.11), p-value = 0.08). In addition, the addition of ACEI,
beta-blocker, or statin use did not significantly change the
primary association between impaired HRR and new-
onset AF among patients (data not shown).
Discussion
In this large, community-based cohort study, we found
that patients with an impaired HRR on ETT were more
likely to experience new-onset AF than patients without
impaired HRR, independent of demographic and clinical
factors. We also demonstrated a trend between increasing
severity of HRR and new-onset AF, and that adjustment
for ACEI, beta-blocker, or statin use did not alter the pri-
mary association. This information provides further clini-
cal support to prior mechanistic studies demonstrating
associations between autonomic dysfunction and AF, and
identifies ETT as an additional tool to explore this rela-
tionship. Moreover, the results of this study suggest that
patients found to have impaired HRR on ETT are at risk for
the development of AF.
By measuring HRR, ETT appears to provide insight into
the autonomic response to exercise, abnormalities of
which have also been demonstrated to independently pre-
dict adverse cardiac outcomes.[17,18] HRR, sometimes
termed vagal reactivation, is related to the capacity of the
cardiovascular system to reverse those autonomic nervous
system adaptations that occur during exercise, and abnor-
malities in HRR are believed to reflect imbalances in auto-
nomic tone, and vagal tone in particular.[19] Imbalances
in autonomic tone, and parasympathetic abnormalities in
particular, have been demonstrated to facilitate the devel-
opment of AF. [2-5] Accordingly, our demonstration of an
association between impaired HRR and AF adds to the
basic physiologic, animal, and clinical observation studies
in supporting the concept of the autonomic nervous sys-
tem as a potential mediator of AF.[2]
Prior studies have demonstrated impaired HRR is a valua-
ble prognostic tool for adverse events, such as all-cause
mortality and cardiovascular events.[6,20-26] However,
to our knowledge, it has not previously been shown to be
associated with AF. By illustrating this association, our
study further underscores the value of ETT as a clinical
tool. Demonstrating associations between impaired HRR
and new-onset AF may also provide potential targets for
AF prevention. For example, prior studies have demon-
strated that, among patients with coronary artery disease,
exercise training enhances vagal tone, improves HRR after
exercise, and reduces morbidity.[27] In addition, a recent
study demonstrated that light to moderate physical activ-
ity was associated with a lower incidence of AF.[28] The
findings of our study provide a potential link between
these prior observations and suggest several future ave-
Study cohort creation Figure 1
Study cohort creation.BMC Cardiovascular Disorders 2009, 9:11 http://www.biomedcentral.com/1471-2261/9/11
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nues for research to understand and manage this
increased risk for incident AF, including additional tests
for autonomic dysfunction to evaluate these patients (e.g.
heart rate variability), and the evaluation of interventions
to prevent or delay the development of AF (e.g. intensive
medical therapies, exercise training).[28,29] In addition,
the prognostic information provided by HRR, which is
routinely collected by most non-invasive laboratories,
also argues for its consistent inclusion in ETT interpreta-
tion reports.
Study limitations
This study has several potential limitations. First, our pop-
ulation was drawn from a single MCO health care system
in Colorado referred specifically for ETT. Although this
may limit the generalizability of our findings, the MCO is
a large integrated healthcare delivery system, with broad
representation of the state's population. In addition,
patients referred for ETT are more likely to be older and
have more cardiac-related co-morbidities than the general
population, making their likelihood of AF development
higher and their subsequent need for its detection and
treatment greater. Second, we were unable to determine
Table 1: Baseline characteristics of patients by heart rate recovery (HRR) on exercise treadmill testing (n = 8236)
Impaired HRR n = 2425 Normal HRR n = 5811 P value
Demographics
Age, median (25th, 75th percentiles), y 63 (54, 70) 54 (47, 63) < 0.0001
Male, No. (%) 1199 (49.4) 3113 (53.6) < 0.001
ETT indications < 0.0001
Chest pain 451 (18.6) 984 (16.9)
Atypical chest pain 920 (37.9) 2953 (50.8)
Risk stratification 200 (8.3) 354 (6.1)
Screening 272 (11.2) 580 (10.0)
Other 582 (24.0) 940 (16.2)
Clinical History
Hypertension, No. (%) 1552 (64) 2487 (42.8) < 0.0001
Diabetes Mellitus, No. (%) 546 (22.5) 619 (10.7) < 0.0001
Lipid disease, No. (%) 1677 (69.2) 3611 (62.1) < 0.0001
Current or recent smoking, No. (%) 393 (16.2) 741 (12.8) < 0.0001
Obese (BMI > = 30), No. (%) 1026 (42.3) 1736 (29.9) < 0.0001
Coronary artery disease, No. (%) 450 (18.6) 629 (10.8) < 0.0001
Congestive heart failure, No. (%) 74 (3.1) 43 (0.7) < 0.0001
COPD, No. (%) 237 (9.8) 145 (2.5) < 0.0001
Mitral valve disease, No. (%) 58 (2.4) 99 (1.7) 0.04
Medications
ACE inhibitor use, No. (%) 596 (24.6) 800 (13.8) < 0.0001
Beta-blocker use, No. (%) 743 (30.6) 1213 (20.9) < 0.0001
- within 72 hours of ETT 558 (23) 929 (16) < 0.0001
Statin use, No. (%) 714 (29.4) 1213 (20.9) < 0.0001
Calcium channel blocker use, No. (%) 195 (8) 214 (3.7) < 0.0001
ACE – angiotensin converting enzyme
BMI – body mass index
COPD – chronic pulmonary obstructive disease
Unadjusted Kaplan-Meier curve of new-onset atrial fibrilla- tion by heart rate recovery on exercise treadmill testing (n =  8236) Figure 2
Unadjusted Kaplan-Meier curve of new-onset atrial 
fibrillation by heart rate recovery on exercise tread-
mill testing (n = 8236).BMC Cardiovascular Disorders 2009, 9:11 http://www.biomedcentral.com/1471-2261/9/11
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whether or not new-onset AF represented paroxysmal,
persistent, or permanent AF. Future studies should seek to
determine if HRR is associated with a particular form of
AF. Finally, as with all observational studies, we are una-
ble to definitively conclude whether this association truly
represents causation.
Conclusion
In conclusion, we found that impaired HRR was signifi-
cantly associated with a higher likelihood of new-onset
AF, independent of patient and clinical factors. Future
research to validate these findings in other populations,
explore the mechanistic links between impaired HRR and
AF, and understand whether patients with impaired HRR
benefit from interventions, such as exercise training, to
delay or prevent new-onset AF are needed.
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